Anzeige
Mehr »
Mittwoch, 10.12.2025 - Börsentäglich über 12.000 News
Diese Biotech-News am 11. Dezember könnte 2026 komplett verändern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YDR2 | ISIN: US5845071076 | Ticker-Symbol: N/A
1-Jahres-Chart
MEDICAL CARE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
MEDICAL CARE TECHNOLOGIES INC 5-Tage-Chart
ACCESS Newswire
291 Leser
Artikel bewerten:
(1)

Medical Care Technologies Inc.: Medical Care Technologies Advances AI Research to Help Identify Early Health Risks in Skin Cancer, Vision, Wound Care, and Mental Wellness

MESA, ARIZONA / ACCESS Newswire / October 9, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a developer of artificial intelligence-powered preventive health technology, today emphasized the urgent human need driving each vertical of its AI platform - underscoring the global lives lost and affected every year to conditions that may be better managed through earlier detection and awareness.

Skin Health

Over 60,000 people die from melanoma and other skin cancers each year. Many are diagnosed too late. MDCE's dermatology module is designed to help users identify visible irregularities earlier through AI-assisted imaging.

Ocular Health

More than 100 million people worldwide experience vision loss from diabetic and vascular eye diseases. MDCE's ocular imaging system aims to analyze retinal patterns that may signal early changes before irreversible damage occurs.

Wound Monitoring

Over 5 million chronic wound and post-surgical infection cases occur annually, often leading to preventable complications. MDCE's wound module seeks to enable continuous image-based tracking for improved recovery oversight.

Mental & Behavioral Health

More than 700,000 lives are lost to suicide every year. MDCE's non-clinical, AI-assisted mental health tracker uses facial micro-expression and emotion-recognition models to explore patterns tied to stress, fatigue, and emotional decline - supporting greater awareness and self-monitoring.

"These global health statistics remind us why early detection and awareness matter," said CEO Marshall Perkins III. "AI cannot replace doctors, but it can help reveal the unseen - and that visibility can make all the difference."

Safe Harbor Statement

This press release contains forward-looking statements based on current expectations regarding future research, technology development, and business outcomes. Such statements are subject to risks and uncertainties that may cause actual results to differ materially, including technical performance, regulatory changes, and operational challenges. Medical Care Technologies Inc. assumes no obligation to update or revise forward-looking statements except as required by law.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC Pink: MDCE) develops AI-based imaging and biometric technologies to promote early health awareness across dermatology, ocular, wound care, and behavioral health. The company is committed to ethical innovation, data transparency, and responsible AI development.

Visit www.medicalcaretechnologies.com for more information.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medical-care-technologies-otc-pink-mdce-advances-ai-research-to-help-1081898

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.